COVID–19 Emergency Medical Supplies Enhancement Act of 2021
United States117th CongressHR-3125House of Representatives
Updated: May 19, 2021
Summary
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Bill texts
All available records shown.
Timeline
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2456-2457)
House of Representatives
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
Motion to reconsider laid on the table Agreed to without objection.
House of Representatives
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Senate